CompaniesSynapDx

SynapDx

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (2)
View all

Total Trials

2

As Lead Sponsor

2

As Collaborator

0

Total Enrollment

1,540

By Status

COMPLETED: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2011
2012
2013
2014
2015
Today
NCT01716845
NCT01810341
Hover over trial bars to see details

Recent Trials

NCT01810341Lead Sponsor
SynapDx Autism Gene Expression Analysis Study (STORY)
N/ACompleted
880 participants
Started: Mar 31, 2013 · Completed: Dec 31, 2014
NCT01716845Lead Sponsor
SynapDx Autism Gene Expression Analysis Study
N/ACompleted
660 participants
Started: Oct 31, 2012 · Completed: Dec 31, 2014
Funding History (2)
D
Jul 25, 2013
Filing
D
Jun 4, 2010
Filing